Previous Meetings

GBCC 2017

Global Breast Cancer Conference 2017

11:10-12:10
Plenary Lecture 1
Past and Future Treatment of HER2-positive Breast Cancer
Venue: Halla Hall
  • Can Anti-HER2 Treatment for Advanced Breast Cancer Disease Be Individualized in 2017?
    Martine Piccart (Institut Jules Bordet, Belgium)
12:10-13:10
Satellite Symposium 1
Venue: Halla Hall
  • The Role of Faslodex in Advanced Breast Cancer Management Pursuing Long Term Treatment Strategy
    Peter Schmid (Barts Cancer Institute, Queen Mary Univ. of London, United Kingdom)
13:30-14:30
Plenary Lecture 2
Venue: Halla Hall
  • What Is the Current Concept of Molecular Portraits of Human Breast Tumors
    Katherine A. Hoadley (On behalf of Prof. Charles M. Perou) (Univ. of North Carolina at Chapel Hill, U.S.A.)
14:40-15:50
Symposium 1
Breast Cancer Prevention and Screening
Venue: Halla Hall
  • Breast Cancer Screening: Harm or Good?
    Steven A Narod (Women's College Research Institute, Women's College Hospital, Dalla Lana School of Public Health, Univ. of Toronto, Canada)
  • Assessment of Breast Cancer Risk with Genetic Polymorphisms
    Antonis Antoniou (Univ. of Cambridge, United Kingdom)
  • Germline Testing for Hereditary Cancer with Multigene Panel
    Po-Han Lin (National Taiwan Univ. Hospital, Taiwan)
Panel Discussion 1
Elderly Breast Cancer
Venue: Lotus Hall
  • Comprehensive Geriatric Assessment for Elderly Patients
    Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
  • Local Therapy
    Seho Park (Yonsei Univ. College of Medicine, Korea)
  • Systemic Therapy
    Janice Tsang (Hong Kong Breast Oncology Group (HKBOG), Hong Kong)
Oral Presentation 1
Venue: Weolla Room
  • POTENTIAL APPLICATION OF GUGGULSTERONE AS A NOVEL ANTAGONIST OF CXCR4 EXPRESSION IN TRIPLE-NEGATIVE BREAST CANCER
    Gautam Sethi (National Univ. of Singapore, Singapore)
  • A RADIOSENSITIVITY GENE SIGNATURE AND PD-L1 STATUS PREDICT CLINICAL OUTCOME OF PATIENTS WITH INVASIVE BREAST CARCINOMA IN THE CANCER GENOME ATLAS (TCGA) DATASET
    Bum-Sup Jang (Seoul National Univ. Hospital, Korea)
  • INTERPLAY BETWEEN MEVALONATE AND HIPPO PATHWAYS REGULATES DDX20 VIA YAP IN INVASIVE BREAST CANCERS
    Chao Wang (National Univ. of Singapore, Singapore)
  • CO-EXISTENCE OF DUCTAL CARCINOMA WITHIN PHYLLODES TUMOR - A REVIEW OF 557 PHYLLODES TUMORS FROM A TWENTY-YEAR REGION-WIDE DATABASE IN HONG KONG AND SHENZHEN, CHINA
    Michael Co (The Univ. of Hong Kong, Hong Kong)
  • RANDOMIZED PHASE III TRIAL OF IRINOTECAN COMBINED WITH CAPECITABINE VERSUS CAPECITABINE IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) PREVIOUSLY TREATED WITH ANTHRACYCLINE AND TAXANES PROCEED TRIAL
    In Hae Park (National Cancer Center, Korea)
  • DETECTION OF SPLICEOMIC SIGNATURES FOR PREDICTING ENDOCRINE RESISTANCE IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER
    Han-Byoel Lee (Seoul National Univ. Hospital, Korea)
  • INHERITED MUTATIONS IN BRCA1 AND BRCA2 IN AN UNSELECTED MULTI-ETHNIC COHORT OF ASIAN BREAST CANCER PATIENTS AND HEALTHY CONTROLS FROM MALAYSIA
    Min Min Tan (Cancer Research Malaysia, Malaysia)
  • CLINICAL APPLICATION OF MULTIGENE PANEL TESTING AND GENETIC COUSELING FOR HEREDITARY/FAMILIAL BREAST CANCER RISK ASSESSMENT: PROSPECTIVE SINGLE CENTER STUDY
    Eun-Shin Lee (Seoul National Univ. College of Medicine, Korea)
16:00-17:10
Education Session 1
New Issues in Cancer Research and Treatment
Venue: Halla Hall
  • Clinical Utility of Liquid Biopsy in Cancer
    Byung-Joo Chae (The Catholic Univ. of Korea, Seoul St. Mary’s Hospital, Korea)
  • Actionable Genome Analysis for Human Cancer
    Woong-Yang Park (Samsung Medical Center, Korea)
  • New Issues in Cancer Genomics for the Research and Treatment
    Tae-Min Kim (College of Medicine, The Catholic Univ. of Korea, Korea)
Panel Discussion 2
Special Issues in Stage IV Breast Cancer
Venue: Lotus Hall
  • Surgery for Stage IV Breast Cancer: No Benefit at All?
    Jin Zhang (Tianjin Medical Univ. Cancer Center, China)
  • New Therapeutic Strategy for CNS Metastases in Breast Cancer
    Hee Kyung Ahn (Gachon Univ. Gil Medical Center, Korea)
  • How Long Should We Treat Patients with Metastatic Breast Cancer? Is Cure Possible?
    Louis Chow (Macau Univ. of Science and Technology, Hong Kong)
Back to Previous Meetings